Literature DB >> 18221133

Recent advances in flavivirus antiviral drug discovery and vaccine development.

Debashish Ray1, Pei-Yong Shi.   

Abstract

Many flaviviruses, including yellow fever virus, dengue virus, Japanese encephalitis virus, tick-borne encephalitis virus, and West Nile virus, are globally important human pathogens. Despite an emergence and resurgence of flavivirus-mediated disease, specific therapies are not yet available; however, significant progress has been made toward the prevention and treatment of flavivirus infections. In this article we review recent advances made in the areas of (i) flavivirus vaccine development, and (ii) antiflavivirus drug discovery reported in literature and patents, and highlight strategies used in these investigations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 18221133     DOI: 10.2174/157489106775244055

Source DB:  PubMed          Journal:  Recent Pat Antiinfect Drug Discov        ISSN: 1574-891X


  19 in total

1.  Structural and functional parameters of the flaviviral protease: a promising antiviral drug target.

Authors:  Sergey A Shiryaev; Alex Y Strongin
Journal:  Future Virol       Date:  2010-09-01       Impact factor: 1.831

2.  Assays for the identification of novel antivirals against bluetongue virus.

Authors:  Linlin Gu; Stewart W Schneller; Qianjun Li
Journal:  J Vis Exp       Date:  2013-10-11       Impact factor: 1.355

Review 3.  Molecular targets for flavivirus drug discovery.

Authors:  Aruna Sampath; R Padmanabhan
Journal:  Antiviral Res       Date:  2008-09-15       Impact factor: 5.970

Review 4.  Closing the door on flaviviruses: entry as a target for antiviral drug design.

Authors:  Rushika Perera; Mansoora Khaliq; Richard J Kuhn
Journal:  Antiviral Res       Date:  2008-06-11       Impact factor: 5.970

5.  Crystal structure of a novel conformational state of the flavivirus NS3 protein: implications for polyprotein processing and viral replication.

Authors:  René Assenberg; Eloise Mastrangelo; Thomas S Walter; Anil Verma; Mario Milani; Raymond J Owens; David I Stuart; Jonathan M Grimes; Erika J Mancini
Journal:  J Virol       Date:  2009-09-30       Impact factor: 5.103

Review 6.  Novel approaches to flavivirus drug discovery.

Authors:  Carolyn Botting; Richard J Kuhn
Journal:  Expert Opin Drug Discov       Date:  2012-03-22       Impact factor: 6.098

7.  Design, synthesis, and in vitro evaluation of potential West Nile virus protease inhibitors based on the 1-oxo-1,2,3,4-tetrahydroisoquinoline and 1-oxo-1,2-dihydroisoquinoline scaffolds.

Authors:  Dengfeng Dou; Prasanth Viwanathan; Yi Li; Guijia He; Kevin R Alliston; Gerald H Lushington; Joshua D Brown-Clay; R Padmanabhan; William C Groutas
Journal:  J Comb Chem       Date:  2010-09-30

8.  The development, optimization and validation of an assay for high throughput antiviral drug screening against Dengue virus.

Authors:  Pulin Che; Lihua Wang; Qianjun Li
Journal:  Int J Clin Exp Med       Date:  2009-12-08

9.  Prediction of protein-protein interactions in dengue virus coat proteins guided by low resolution cryoEM structures.

Authors:  Rupali A Gadkari; Narayanaswamy Srinivasan
Journal:  BMC Struct Biol       Date:  2010-06-16

10.  The two-component NS2B-NS3 proteinase represses DNA unwinding activity of the West Nile virus NS3 helicase.

Authors:  Andrei V Chernov; Sergey A Shiryaev; Alexander E Aleshin; Boris I Ratnikov; Jeffrey W Smith; Robert C Liddington; Alex Y Strongin
Journal:  J Biol Chem       Date:  2008-04-28       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.